Sparsentan

CAS 188116-07-6VET
Anticonvulsant

Opioid use disorder

CAS 1369852-71-0Demodex Blepharitis

CAS 1369852-71-0Control Fleas & Ticks

Acute myeloid leukemia
Myelodysplastic syndrome

CAS 1345728-04-2Opioid-induced Constipation

CAS 79338-94-4Plaque Psoriasis

Tipiracil HCl / Trifluridine Colonrectal and Gastric cance

CAS 6411-75-2

Is a non-steroidal anti-inflammatory drug that veterinarians prescribe as a supportive treatment for various conditionsbrhrbrAnti-inflammatory

CAS 511-13-7brhrbrAntitussive

CAS 6170-42-9brhrbrAntihistaminic

After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October 2023. In this series of interviews, we speak to the people and teams behind the award-winning projects, concepts, technologies, and in this case, the CEOs that make a difference. 

We are extremely proud and happy with this CPhI Edition, not only from business point of view, but also for the recognition received at the CPhI Pharma Awards. Enthusiasm, insightful conversations, and shared passion are the keyword for this CPhI Barcelona, and we can't thank you enough for your support.

Dr. Enrico Zodio, CEO of Procos S.p.a, speaks with CPHI TV at CPHI Worldwide in Madrid.